Literature DB >> 15144567

Diagnostic utility of pleural fluid IFN-gamma in tuberculosis pleural effusion.

S K Sharma1, Amit Banga.   

Abstract

Pleural fluid interferon-gamma (IFN-gamma) levels are increased in patients with tuberculosis (TB) pleural effusion. Recent studies from the west have found that estimation of pleural fluid IFN-gamma levels is an excellent diagnostic strategy for these patients. The diagnostic utility of pleural effusion IFN-gamma level estimation has not been evaluated in patients from developing countries, however. This work was carried out to study the diagnostic utility of IFN-gamma level estimation in patients with TB pleural effusion and to define the best cutoff of IFN-gamma for diagnosis TB pleural effusion. We studied 101 patients with pleural effusion. Of these, 64 were found to have a TB etiology, established by means of various conventional modalities. Measurement of pleural fluid IFN-gamma levels was done by ELISA technique. The median value of pleural fluid IFN-gamma levels in patients with TB (1480 pg/ml, range 3-14,000 pg/ml) was significantly higher (p < 0.001) compared with the non-TB group (3 pg/ml, range 0-900 pg/ml). The receiver operator characteristic (ROC) curve for IFN-gamma showed an area under the curve (AUC) value of 0.954, and the best cutoff was computed to be 138 pg/ml. Using this cutoff for IFN-gamma levels in pleural fluid for the diagnosis of TB, sensitivity, specificity, negative predictive value, and positive predictive value were found to be 90.2%, 97.3%, 85.7%, and 98.3%, respectively. Estimation of IFN-gamma levels in pleural fluid is a useful diagnostic modality for TB pleural effusion. A cutoff of 138 pg/ml provides the best sensitivity and specificity for diagnosis of TB.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15144567     DOI: 10.1089/107999004323034088

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  7 in total

1.  Markers for differentiation of tubercular pleural effusion from non-tubercular effusion.

Authors:  Vivek Ambade; M M Arora; S P Rai; S K Nikumb; D R Basannar
Journal:  Med J Armed Forces India       Date:  2011-10-22

2.  Diagnosis and management of miliary tuberculosis: current state and future perspectives.

Authors:  Sayantan Ray; Arunansu Talukdar; Supratip Kundu; Dibbendhu Khanra; Nikhil Sonthalia
Journal:  Ther Clin Risk Manag       Date:  2013-01-08       Impact factor: 2.423

Review 3.  Challenges in the diagnosis & treatment of miliary tuberculosis.

Authors:  Surendra K Sharma; Alladi Mohan; Abhishek Sharma
Journal:  Indian J Med Res       Date:  2012-05       Impact factor: 2.375

4.  Evaluation of immune responses in HIV infected patients with pleural tuberculosis by the QuantiFERON TB-Gold interferon-gamma assay.

Authors:  Kamaldeen Baba; Steinar Sørnes; Anwar A Hoosen; Jacob M Lekabe; Mathew J Mpe; Nina Langeland; Anne M Dyrhol-Riise
Journal:  BMC Infect Dis       Date:  2008-03-14       Impact factor: 3.090

Review 5.  Cytokines as Biomarkers and Their Respective Clinical Cutoff Levels.

Authors:  Rebecca N Monastero; Srinivas Pentyala
Journal:  Int J Inflam       Date:  2017-04-09

Review 6.  Miliary tuberculosis: A new look at an old foe.

Authors:  Surendra K Sharma; Alladi Mohan; Animesh Sharma
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2016-03-18

7.  Diagnostic value of pleural fluid interferon-gamma and adenosine deaminase in patients with pleural tuberculosis in Qatar.

Authors:  Fahmi Yousef Khan; Maha Hamza; Aisha Hussein Omran; Muhannad Saleh; Mona Lingawi; Adel Alnaqdy; Mohamed Osman Abdel Rahman; Hasan Syed Ahmedullah; Alan Hamza; Ahmed Al Ani; Mehdi Errayes; Mona Almaslamani; Ahmed Ali Mahmood
Journal:  Int J Gen Med       Date:  2013-01-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.